AGEN.NASDAQAgenus INC

Form 4: Agenus Director Susan Hirsch Acquires Stock Options

Sentiment:

Statement of Changes in Beneficial Ownership


Director Susan Hirsch of Agenus Inc. was granted stock options for 105,000 shares.

Summary

  • Susan B. Hirsch, a Director at Agenus Inc., has been granted stock options.
  • The options are for 105,000 shares of common stock.
  • The grant was made under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan.
  • The options have an exercise price of $3.90 per share.
  • These options vest on the one-year anniversary of the grant date, which is April 24, 2026.
  • The options are exercisable until April 24, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation grant to a director rather than a significant financial event or strategic shift.

Positives

  • Director compensation through stock options can align management interests with shareholders.
  • The grant of options suggests confidence in the company's future prospects by management.

Risks

  • The value of the stock options is dependent on the future stock price performance of Agenus Inc.
  • If the stock price does not exceed the exercise price of $3.90, the options may not be exercised profitably.

Future Outlook

The stock options are exercisable until April 24, 2036, with vesting occurring one year after the grant date of April 24, 2026. The exercise price is $3.90.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, aiming to incentivize long-term performance and align executive interests with shareholder value.

Stakeholder Impact

  • Shareholders: The grant of options dilutes existing ownership slightly but aligns director incentives with stock performance.
  • Directors: Susan Hirsch benefits from potential future gains if the stock price increases above the exercise price.

Next Steps

  • The stock options will vest on the one-year anniversary of the grant date.
  • The options can be exercised by the holder until their expiration date.

Key Dates

DateDescription
04/24/2026Earliest transaction date and grant date of stock options.
04/24/2036Expiration date of the stock options.
04/28/2026Date the statement was signed.

Keywords

stock options, Agenus Inc., director compensation, equity incentive plan, beneficial ownership, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.